Hadassah

ALS Stem Cell Trial Yielding “Impressively Positive” Findings

Thursday, Jan 2 2014

Commenting on the Phase IIa trial of NurOwn™--BrainStorm Cell Therapeutics' stem cell therapy for amyotrophic lateral sclerosis (ALS)--which is being conducted at the Hadassah Medical Organization, Prof. Dimitrios Karussis, principal investigator, reports that the safety data are "impressively positive" and that the "initial indications of clinical efficacy" are cause for optimism regarding the management of ALS and the future of cell therapies for neurodegenerative diseases in general.

Prof. Karussis, Neurologist and Director of the Multiple Sclerosis Center at Hadassah, presented some of his preliminary findings from this ongoing dose-escalating trial at the 24th International Symposium on ALS/MND in Milan, Italy. MND, Motor Neuron Disease, is the name given to a group of diseases in which the nerve cells (neurons) that control muscles undergo degeneration and die.

According to Prof. Karussis, although the final data are not yet available for publication because the trial is still ongoing, researchers have met with only minimal and transient adverse effects, even though the patients in the study were given the treatment both intrathecally (into the cerebrospinal fluid by injection into the subarachnoid space of the spinal cord) and intramuscularly, with up to double the dose of the stem cells given in the Phase I trial.

At the conclusion of the clinical trial, BrainStorm will release the complete set of data and corresponding analyses.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Jan 10 2017

From Locked Jaw to Osteoarthritis: Hadassah Discovery Leads to New Treatment

What began as a solution to locked jaw--temporomandibular joint (TMJ) disorder--has led to the creation of a novel non-opioid pharmaceutical candidate for the treatment of osteoarthritis pain, thanks to a Hadassah Medical Organization discovery and collaboration with colleagues at the Hebrew University and the Technion.

READ MORE ›
alt_text

Monday, Jan 9 2017

Soldiers Rushed to Hadassah After Sunday's Terrorist Attack

On Sunday January 8, four soldiers were killed and 17 wounded, when a terrorist rammed his vehicle into them.

READ MORE ›
alt_text

Monday, Jan 9 2017

Prime Minister Netanyahu visits terror survivors at Hadassah Hospital

Prime Minister Benjamin Netanyahu and Health Minister Yaakov Litzman visited terror victims hospitalized at Hadassah Hospital Ein Kerem after a terrorist rammed his flatbed truck into a group of soldiers on an IDF cultural field trip in Jerusalem. Four were killed, and 11 patients underwent treatment at Hadassah hospitals: 9 at Ein Kerem and 2 at Mount Scopus.

READ MORE ›
alt_text

Friday, Jan 6 2017

World-First Newborn Intestinal Surgery Saves Baby Girl at Hadassah

A baby girl whose intestines formed outside of her abdomen was saved by a world-first surgical procedure following her birth at Hadassah Hospital Ein Kerem.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More